Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Artificial Intelligence in Cardiomyopathies: From Opportunistic Detection to Decision-Critical Risk Stratification.

Created on 17 Nov 2026

Authors

Emanuele Bobbio, Sabrina Montuoro, Vera Fico, Emanuele Monda, Mario Merone, Leandro Pecchia, Giuseppe Limongelli

Published in

Heart failure clinics. Volume 23. Issue 1. Pages 67-79. Epub Oct 23, 2026.

Abstract

This article examines the evolving role of artificial intelligence (AI) across the continuum of care in cardiomyopathies, from opportunistic screening to decision-critical risk stratification. AI-enhanced electrocardiography enables scalable early detection, while advanced echocardiographic and cardiac magnetic resonance-based radiomics refine myocardial substrate characterization. Multimodal models integrating imaging, electrical, and clinical data refine risk stratification beyond conventional metrics such as left ventricular ejection fraction. However, clinical translation requires external validation, calibration stability, interpretability, and structured workflow integration. AI emerges not as autonomous diagnosis, but as accountable, clinician-supervised decision support embedded within multidisciplinary cardiovascular care.

PMID:
43039586
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement